196 related articles for article (PubMed ID: 32445444)
1. A Review on the Progress and Prospects of Dengue Drug Discovery Targeting NS5 RNA- Dependent RNA Polymerase.
Maddipati VC; Mittal L; Mantipally M; Asthana S; Bhattacharyya S; Gundla R
Curr Pharm Des; 2020; 26(35):4386-4409. PubMed ID: 32445444
[TBL] [Abstract][Full Text] [Related]
2. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
3. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
[TBL] [Abstract][Full Text] [Related]
4. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase.
Kumar S; Bajrai LH; Faizo AA; Khateb AM; Alkhaldy AA; Rana R; Azhar EI; Dwivedi VD
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016449
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on the current antiviral developments towards RNA-dependent RNA polymerase (RdRp) and methyltransferase (MTase) domains of dengue virus non-structural protein 5 (DENV-NS5).
Sreekanth GP
Eur J Med Chem; 2023 Aug; 256():115416. PubMed ID: 37159959
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of dengue virus polymerase by blocking of the RNA tunnel.
Niyomrattanakit P; Chen YL; Dong H; Yin Z; Qing M; Glickman JF; Lin K; Mueller D; Voshol H; Lim JY; Nilar S; Keller TH; Shi PY
J Virol; 2010 Jun; 84(11):5678-86. PubMed ID: 20237086
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
[TBL] [Abstract][Full Text] [Related]
10. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
[TBL] [Abstract][Full Text] [Related]
11. [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
Wan YH; Wu WY; Guo SX; He SJ; Tang XD; Wu XY; Nandakumar KS; Zou M; Li L; Chen XG; Liu SW; Yao XG
Acta Pharmacol Sin; 2020 May; 41(5):706-718. PubMed ID: 31729469
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
[TBL] [Abstract][Full Text] [Related]
13. Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.
Lim SP; Noble CG; Seh CC; Soh TS; El Sahili A; Chan GK; Lescar J; Arora R; Benson T; Nilar S; Manjunatha U; Wan KF; Dong H; Xie X; Shi PY; Yokokawa F
PLoS Pathog; 2016 Aug; 12(8):e1005737. PubMed ID: 27500641
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, discovery and SAR of the fused tricyclic derivatives of indoline and imidazolidinone against DENV replication and infection.
Qian W; Xue JX; Xu J; Li F; Zhou GF; Wang F; Luo RH; Liu J; Zheng YT; Zhou GC
Bioorg Chem; 2022 Mar; 120():105639. PubMed ID: 35093691
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase.
Shimizu H; Saito A; Mikuni J; Nakayama EE; Koyama H; Honma T; Shirouzu M; Sekine SI; Shioda T
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007894. PubMed ID: 31738758
[TBL] [Abstract][Full Text] [Related]
16. The Transactions of NS3 and NS5 in Flaviviral RNA Replication.
Tay MYF; Vasudevan SG
Adv Exp Med Biol; 2018; 1062():147-163. PubMed ID: 29845531
[TBL] [Abstract][Full Text] [Related]
17. Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors.
Nascimento IJDS; Santos-Júnior PFDS; Aquino TM; Araújo-Júnior JX; Silva-Júnior EFD
Eur J Med Chem; 2021 Nov; 224():113698. PubMed ID: 34274831
[TBL] [Abstract][Full Text] [Related]
18. SUMO Modification Stabilizes Dengue Virus Nonstructural Protein 5 To Support Virus Replication.
Su CI; Tseng CH; Yu CY; Lai MMC
J Virol; 2016 May; 90(9):4308-4319. PubMed ID: 26889037
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of novel non-nucleoside class of molecules inhibiting the dengue virus replication.
Roy KK; Jyothi D; Paul U; Sukla S
J Biomol Struct Dyn; 2023; 41(23):13993-14002. PubMed ID: 36970872
[TBL] [Abstract][Full Text] [Related]
20. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
